E89.838 Código facturable y específico Other postprocedural hypoglycemia
ICD-10-CM E89.838 identifies “Other postprocedural hypoglycemia” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Capítulo 4: Endocrine, nutritional and metabolic diseases
Instrucciones del código
Inclusion terms1
Post Nissen fundoplication hypoglycemia
Instrucciones de niveles superiores
E89.83 · Postprocedural hypoglycemia following a procedure
Use additional code1
code, if known, for hypoglycemia level (E16.A-)
Capítulos 4 · Endocrine, nutritional and metabolic diseases (E00-E89)
Excludes 11
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Note1
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E89 · Postprocedural endocrine and metabolic complications and disorders, not elsewhere classified
Referencias del índice oficial
Referencias del índice oficial (2)
Hypoglycemia(spontaneous) (2)
- Hypoglycemia(spontaneous) › post Nissen fundoplicationÍndice de enfermedades
- Hypoglycemia(spontaneous) › postproceduralÍndice de enfermedades
Historial oficial de conversión
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Asignación anterior: E89.89
Historial
Historial del código
Último cambio registrado · FY2027
Vigente desde
- Añadido
Other postprocedural hypoglycemia
Código de diagnóstico facturable
CDC/NCHS · FY2027Todas las ediciones (1)
| Todas las ediciones | Vigente desde | Historial del código |
|---|---|---|
| FY2027 | 2026-10-01 | Añadido |
Esta entrada es un código completo en la edición seleccionada. La comprobación del catálogo no establece la pertinencia clínica ni garantiza el reembolso.